Category

• Products3
• Archives1

Organizations

• Bausch + Lomb64
• Eyes On Eyecare42
• Alcon, Inc.41
• American Optometric Association34
• Harrow26
• Glaukos25
• Regeneron21
• Aldeyra Therapeutics20
• Sight Sciences19
• American Academy Of Ophthalmology18

Tags

• Artificial Intelligence3
• Diabetic Retinopathy3
• Technology3
• Retina2
• FDA1
• Atropine1
• Diagnosis1
• Imaging1

• Organizations: AEYE Health✕

Clear all

Products

FDA clears first-ever fully autonomous AI portable DR screening

AEYE Health’s AEYE Diagnostic Screening is designed to detect diabetic retinopathy in adult patients in just 1 minute.

Products

IRIS partners with AEYE health for AI-based DR screening

Collaboration will integrate the AEYE’s FDA-cleared technology with the IRIS software for diabetic retinopathy screenings.

Archives

New FDA approval for a diabetic retinopathy screening tool. — Weekly Glance

AEYE Health has received FDA clearance to market its diagnostic screening system for diabetic retinopathy.

Products

FDA clears AI-based diagnostic screening for DR

AEYE Health has been granted 501(k) clearance from the FDA for its artificial intelligence (AI) diagnostic screening system for diabetic retinopathy (DR).